Site 0104 - Dana Farber Cancer Institute — Boston, Massachusetts

Site 0104 - Dana Farber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 0104 - Dana Farber Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Sponsors: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

• Massachusetts General Hospital Translational and Clinical Research Center
• Boston VA CSP Coordinating Center
• Boston Children's Hospital / Dana Farber Cancer Institute / Massachusetts General Hospital
• Massachusetts General Hospital Site Number : 002
• Laboratories of Cognitive Neuroscience, Boston Children's Hospital
• The Brigham and Women's Hospital Department of Anesthesiology
• Tuft University Hospital
• Boston Children's Hospital /ID# 162863
• Dana Farber Cancer Institute/Children's Hospital of Boston
• Brigham and Women's Hospital
• Brigham & Woman's Hospital/Boston
• Caritus St. Elizabeth's Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 0104 - Dana Farber Cancer Institute?

Site 0104 - Dana Farber Cancer Institute has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 0104 - Dana Farber Cancer Institute conducted?

Site 0104 - Dana Farber Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Is Site 0104 - Dana Farber Cancer Institute accredited by Crixeo Clinical Trials?

Site 0104 - Dana Farber Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 0104 - Dana Farber Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.